CBLL - CeriBell, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$30.00
DETAILS
HIGH:
$30.00
LOW:
$30.00
MEDIAN:
$30.00
CONSENSUS:
$30.00
UPSIDE:
50.75%
Market Cap:
738.20M
Volume:
256,098
Avg Volume:
445,505
52 Week Range:
10.01-26.04
Sector:
Healthcare
Industry:
Medical - Devices
Beta:
1.01
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
281
IPO Date:
2024-10-11
EPS (TTM):
-3.39
P/E Ratio:
-15.00
Revenue (TTM):
65.44M
Total Assets:
225.41M
Total Debt:
21.96M
Cash & Equiv:
194.37M
Rev Growth (5Y):
58.8%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-18.1%
Debt/Equity:
0.11
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-02-24 | $-0.36 | $-0.43 | +15.5% | $24.8M | $23.9M | +3.5% |
| 2025-11-04 | $-0.37 | $-0.43 | +14.0% | $22.6M | $23.9M | -5.7% |
| 2025-08-05 | $-0.38 | $-0.40 | +5.0% | $21.2M | $21.8M | -2.6% |
| 2025-05-08 | $-0.36 | $-0.43 | +16.3% | $20.5M | $20.5M | -0.3% |
| 2025-02-25 | $-0.40 | $-0.32 | -25.0% | $18.5M | $19.3M | -4.0% |
| 2024-11-12 | $-1.85 | $-0.82 | -125.6% | $17.2M | $17.5M | -2.0% |
| 2024-10-11 | $-1.59 | — | — | $14.9M | — | — |
| 2024-03-31 | $-1.59 | — | — | $14.9M | — | — |
| Metric | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 65.44M | 45.23M | 25.92M |
| Net Income | (40.45M) | (29.46M) | (37.16M) |
| EPS | -3.39 | -1.26 | -1.59 |
| Total Assets | 225.41M | 58.92M | 86.46M |
| Total Debt | 21.96M | 14.20M | 18.22M |
| Cash & Equivalents | 194.37M | 34.49M | 68.23M |
| Operating Cash Flow | (35.04M) | (29.16M) | (32.00M) |
| Free Cash Flow | (36.38M) | (30.14M) | (32.52M) |
| FCF per Share | -3.04 | -1.29 | -1.39 |
| Book Value | 191.16M | (112.25M) | (86.40M) |
| Cash & ST Investments | 194.37M | 34.49M | 68.23M |
| ROC Equity | -0.21 | N/A | N/A |